Sites of metastasis (mets) and association with clinical outcomes (CO) in metastatic renal cell carcinoma (mRCC) patients (pts) treated with cabozantinib (cabo).

fDepartment of Medical Oncology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON, Canada gSunnybrook Odette Cancer Centre, University of Toronto, Toronto ...

Meanwhile, the Department of Fisheries and Aquatic Resources, alerted the Maritime Rescue Coordination Centre (MRCC) Colombo, located at the Navy Headquarters, about the situation and requested ...

Dr. Yoshie Mita presented a study evaluating the prognostic impact of the maximal evaluable lesion size in patients with metastatic renal cell carcinoma (mRCC) treated with combination nivolumab + ...